Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

732 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study.
Trestini I, Belluomini L, Dodi A, Sposito M, Caldart A, Kadrija D, Pasqualin L, Riva ST, Scaglione IM, Tregnago D, Avancini A, Insolda J, Confortini L, Casali M, Menis J, Vita E, Cintoni M, Todesco M, Milanese G, Sperduti I, D'Onofrio M, Infante M, Tiseo M, Mele MC, Tortora G, Milella M, Bria E, Pilotto S. Trestini I, et al. Among authors: tortora g. J Cachexia Sarcopenia Muscle. 2024 Dec;15(6):2349-2360. doi: 10.1002/jcsm.13568. Epub 2024 Oct 22. J Cachexia Sarcopenia Muscle. 2024. PMID: 39439222 Free PMC article.
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study.
Iacovelli R, Ciccarese C, Buti S, Zucali PA, Fantinel E, Bimbatti D, Verzoni E, Accettura C, Bonomi L, Buttigliero C, Fornarini G, Pipitone S, Atzori F, Masini C, Massari F, Primi F, Strusi A, Giudice GC, Perrino M, Maruzzo M, Milella M, Giannarelli D, Brunelli M, Procopio G, Tortora G. Iacovelli R, et al. Among authors: tortora g. Eur Urol. 2024 Nov;86(5):411-419. doi: 10.1016/j.eururo.2024.02.014. Epub 2024 Mar 22. Eur Urol. 2024. PMID: 38521617 Free article. Clinical Trial.
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK-positive advanced non-small cell lung cancer.
Vita E, Monaca F, Milardi D, Mastrantoni L, Stefani A, Vergani E, Russo J, Barone D, Sparagna I, Vitale A, Scala A, Occhipinti D, Di Salvatore M, Pontecorvi A, Tortora G, Bria E. Vita E, et al. Among authors: tortora g. Cancer. 2024 Aug 1;130(15):2611-2620. doi: 10.1002/cncr.35293. Epub 2024 Mar 28. Cancer. 2024. PMID: 38549441
Preoperative low skeletal muscle mass index assessed using L3-CT as a prognostic marker of clinical outcomes in pancreatic cancer patients undergoing surgery: a systematic review and meta-analysis.
Raoul P, Cintoni M, Coppola A, Alfieri S, Tortora G, Gasbarrini A, Mele MC, Rinninella E. Raoul P, et al. Among authors: tortora g. Int J Surg. 2024 Oct 1;110(10):6126-6134. doi: 10.1097/JS9.0000000000000989. Int J Surg. 2024. PMID: 38836800 Free PMC article.
To explain the unexplainable in MONARCH 3 overall survival: the restricted mean survival time. Letter to the Editor regarding 'Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: Final overall survival results of MONARCH 3' by M. P. Goetz et al.
Orlandi A, Mastrantoni L, Bria E, Tortora G. Orlandi A, et al. Among authors: tortora g. Ann Oncol. 2024 Aug;35(8):748-749. doi: 10.1016/j.annonc.2024.05.544. Epub 2024 Jun 3. Ann Oncol. 2024. PMID: 38838845 No abstract available.
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis.
Ciccarese C, Anghelone A, Stefani A, Cigliola A, Strusi A, D'Agostino F, Bria E, Iacovelli R, Tortora G. Ciccarese C, et al. Among authors: tortora g. Expert Rev Anticancer Ther. 2024 Jul;24(7):623-633. doi: 10.1080/14737140.2024.2357814. Epub 2024 Jun 16. Expert Rev Anticancer Ther. 2024. PMID: 38879826 Review.
Outcomes of Radiotherapy in Oligoprogressive Breast Cancer.
Marazzi F, Masiello V, Orlandi A, Moschella F, Chiesa S, Di Leone A, Garufi G, Mazzarella C, Sanchez AM, Casa C, Bucaro A, De Lauretis F, Borghesan N, Tagliaferri L, Franceschini G, Bria E, Masetti R, Fabi A, Aristei C, Tortora G, Valentini V, Gambacorta MA. Marazzi F, et al. Among authors: tortora g. J Pers Med. 2024 Jul 29;14(8):805. doi: 10.3390/jpm14080805. J Pers Med. 2024. PMID: 39201997 Free PMC article.
The likelihood of being helped or harmed as a patient-centred tool to assess ALK-Inhibitors clinical impact and safety in ALK-addicted non-small cell lung cancer: A systematic review and sensitivity-analysis.
Mastrantoni L, Giordano G, Vita E, Horn G, Russo J, Orlandi A, Daniele G, Giannarelli D, Tortora G, Bria E. Mastrantoni L, et al. Among authors: tortora g. Cancer Treat Res Commun. 2024;41:100842. doi: 10.1016/j.ctarc.2024.100842. Epub 2024 Sep 6. Cancer Treat Res Commun. 2024. PMID: 39260066 Free article. Review.
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis.
Mastrantoni L, Chiaravalli M, Spring A, Beccia V, Di Bello A, Bagalà C, Bensi M, Barone D, Trovato G, Caira G, Giordano G, Bria E, Tortora G, Salvatore L. Mastrantoni L, et al. Among authors: tortora g. Lancet Oncol. 2024 Dec;25(12):1655-1665. doi: 10.1016/S1470-2045(24)00511-4. Epub 2024 Nov 11. Lancet Oncol. 2024. PMID: 39542008
732 results